Companies / Latvia
Latvia's Reimbursement Budget Balloons
June 2006 | Market Trend AnalysisLatvia's reimbursement budget for this year has been increased by 40% to EUR61mn (US$77mn), indicating that the country's drugs market is maturing quicker than expected. However, patients will be expected to pay for around of half of total pharmaceutical spending in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
